Although off-target effects of PCG cannot be completely excluded in this study, our findings nonetheless demonstrate that PCG exerts therapeutic effects on atopic dermatitis, at least in part, through inhibition of PAR2 activity. Here, F2RL1 is linked to atopic eczema.